HHS filed a motion for summary judgement against Kalderos, the drug industry vendor behind Eli Lilly’s rebate proposal.

Trump’s HHS Continues to Oppose Unilateral Drugmaker 340B Rebates in Kalderos Lawsuit

March 20, 2025 Bella Czajkowski, National Correspondent 340B Report Views

The Trump administration this week continued to oppose drug industry attempts to unilaterally convert 340B discounts to a rebate model, [...]

Please Login or Become a Paid Subscriber to View this Content

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!